Diagnostic imaging provider Capitol Health (ASX:CAJ) was one of several companies continuing to steam through the reporting season in Australia.

Capitol told investors that its underlying NPAT (net profit after tax) for the 2024 fiscal year had increased by a quarter of a percent (25%) to $11 million compared to the previous year, while revenue had also grown for the same period, by 12% to $238 million.

In a year when Capitol had announced a proposed merger with $Integral Diagnostics Ltd (IDX.AU)$ and opened new MRI comprehensive clinic at Sunshine Private Hospital in Victoria, the company said its final dividend for FY2024 would be declared in line with merger ratio (with this being 0.12849 of the FY2024 final dividend of IDX).

Meanwhile, $Genesis Energy Ltd (GNE.AU)$ posted a significant fall in profit during the 12-month period to June 2024.

In its full statutory accounts, Genesis said its net profit was down 33% to $131.1 million compared to $195.8 million in the previous fiscal year.

This was also reflected in the company's EBITDAF (earnings before interest, tax, depreciation, amortisation, fair value movements of financial instruments, investment costs, realisations and impairments), which came in at $407.2 million in FY2024, a fall of 22% from the figure of $523.5 million in FY2023.

Genesis said its 'strategy was on track despite a challenging year' impacted by constraints in gas supply, low hydro and wind levels, and a 7-month outage at Huntly Unit 5.

Its total dividends per share for FY2024 were 14 cps, compared to 17.6 cps in FY2023, a fall of 21%.

An annual report was also out from casino operator $SkyCity Entertainment Group Ltd (SKC.AU)$, who said that underlying group NPAT had fallen 7.2% TO NZ$123.2 million, reflecting lower earnings.

EBITDA was also down 8% to NZ$277.8 million, and CEO Jason Walbridge said the weaker figures overall were underpinned by cost-of-living pressures, a softer economy, and SkyCity's requirement to respond to certain regulatory issues.

SkyCity previously announced that it would be closing gambling operations at its Auckland site for five days next month, and this was set to cost the company NZ$5 million in expected earnings for FY2025.

The decision was made as part of an agreement between management and the Secretary of Internal Affairs in order to avoid the temporary suspension of the company's casino operator's licence.

Underlying earnings per share were 16.2 cps for FY2024, a fall of 7.3% year on year.

$Medibank Private Ltd (MPL.AU)$ reported a strong suite of results today, with underlying NPAT coming in at $570.4 million for the 2024 fiscal year: a rise of 14.1% from the previous reporting period.

CEO David Koczkar said the priority for Medibank had been on keeping premiums low and providing support for customers, as reflected in a $305 million COVID give back, which brought total customer support to a record $1.46 billion during the period.

The company's final ordinary dividend (fully franked) was 9.4 cps.

In terms of share price, Medibank shares have been trading at $3.92, SkyCity shares at $1.45, Genesis shares at $2.07, and Capitol Health shares at 29.5 cents.